{"id":"NCT01975675","sponsor":"Gilead Sciences","briefTitle":"Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection","officialTitle":"A Phase 3b, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Treatment-Naïve and Treatment-Experienced Japanese Subjects With Chronic Genotype 1 HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-06","completion":"2014-08","firstPosted":"2013-11-05","resultsPosted":"2015-06-26","lastUpdate":"2018-11-16"},"enrollment":341,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic HCV Infection"],"interventions":[{"type":"DRUG","name":"LDV/SOF","otherNames":["GS-7977","PSI-7977","GS-5885"]},{"type":"DRUG","name":"RBV","otherNames":["Copegus®"]}],"arms":[{"label":"LDV/SOF (treatment naive)","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV (treatment naive)","type":"EXPERIMENTAL"},{"label":"LDV/SOF (treatment experienced)","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV (treatment experienced)","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the antiviral efficacy of sofosbuvir (SOF)/ledipasvir (LDV) fixed-dose combination (FDC) tablet with or without ribavirin (RBV) in treatment-naive or treatment-experienced Japanese participants with chronic genotype 1 HCV infection. Participants receive 12 weeks of treatment and continue assessments during a 24-week posttreatment follow-up period.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) at 12 Weeks After Discontinuation of Therapy (SVR12), Treatment-naive, Noncirrhotic Participants","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"LDV/SOF (Treatment Naive)","deltaMin":100,"sd":null},{"arm":"LDV/SOF+RBV (Treatment Naive)","deltaMin":97.2,"sd":null}],"pValues":[{"comp":"OG000","p":"< 0.001"},{"comp":"OG001","p":"< 0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":19,"countries":["Japan"]},"refs":{"pmids":["25863559"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":171},"commonTop":["Nasopharyngitis","Headache","Anaemia","Pruritus","Rash"]}}